| Pharmaceutical active ingredients: |
| GuaifenesinPhenylephrine Hydrochloride |
| Available forms, composition and doses of ExeFen-PD: |
| N / A |
| ExeFen-PD medical category: |
| Human:Expectorants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA53 - Phenylephrine, combinationsR05CA03 - GuaifenesinR05CA10 - Expectorants, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Larken Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Duraphen II | Guaifenesin; Phenylephrine Hydrochloride | ProEthic Pharmaceuticals |
| Duratuss | Guaifenesin; Phenylephrine Hydrochloride | Victory Pharmaceuticals |
| Duratuss GP | Guaifenesin; Phenylephrine Hydrochloride | Victory Pharmaceuticals |
| Endal | Guaifenesin; Phenylephrine Hydrochloride | PediaMed Pharmaceuticals |
| Entex | Guaifenesin; Phenylephrine Hydrochloride | Andrx Pharmaceuticals; Purdue Pharma |
| GFN Phenylephrine | Guaifenesin; Phenylephrine Hydrochloride | Cypress Pharmaceutical |
| Guaifed | Guaifenesin; Phenylephrine Hydrochloride | Victory Pharmaceuticals |
| Guaifed-PD | Guaifenesin; Phenylephrine Hydrochloride | Victory Pharmaceuticals |
| Liquibid-D | Guaifenesin; Phenylephrine Hydrochloride | Capellon Pharmaceuticals |
| Liquibid-PD | Guaifenesin; Phenylephrine Hydrochloride | Capellon Pharmaceuticals |